Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Moore

Showing results (291-300 of 354) with videos related to

Pageof 36
Sort By:
Pharmacoepidemiology and Drug Safety|March 6, 2020
Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE projectNicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Atherosclerosis|January 19, 2019
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims databasePatrick Blin, Caroline Dureau-Pournin, Jacques Benichou, et al.
Current Medical Research and Opinion|September 7, 2023
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosisHelmut Butzkueven, Jan Hillert, Merja Soilu-Hänninen, et al.
Neurourology and Urodynamics|September 21, 2006
Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized studyMarianne de Sèze, Philippe Gallien, Pierre Denys, et al.
Intensive Care Medicine|July 27, 2007
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospitalMarieke Grenouillet-Delacre, Hélène Verdoux, Nicholas Moore, et al.
Pharmacoepidemiology and Drug Safety|June 12, 2020
Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS)Nicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Pharmacoepidemiology and Drug Safety|October 25, 2020
Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS)Nicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Particle and Fibre Toxicology|September 22, 2007
Physicochemical characteristics and bronchial epithelial cell cytotoxicity of Folpan 80 WG(R) and Myco 500(R), two commercial forms of folpetMireille Canal-Raffin, Beatrice L'azou, Beatrice Martinez, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 8, 2018
Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) studyPierre-Michel Llorca, Julio Bobes, W Wolfgang Fleischhacker, et al.
Cardiovascular Diabetology|November 26, 2021
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims databasePatrick Blin, Patrice Darmon, Patrick Henry, et al.
Pageof 36

Showing results (291-300 of 354) with videos related to

Sort By:
Pageof 36
Pharmacoepidemiology and Drug Safety|March 6, 2020
Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE projectNicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Atherosclerosis|January 19, 2019
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims databasePatrick Blin, Caroline Dureau-Pournin, Jacques Benichou, et al.
Current Medical Research and Opinion|September 7, 2023
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosisHelmut Butzkueven, Jan Hillert, Merja Soilu-Hänninen, et al.
Neurourology and Urodynamics|September 21, 2006
Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized studyMarianne de Sèze, Philippe Gallien, Pierre Denys, et al.
Intensive Care Medicine|July 27, 2007
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospitalMarieke Grenouillet-Delacre, Hélène Verdoux, Nicholas Moore, et al.
Pharmacoepidemiology and Drug Safety|June 12, 2020
Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS)Nicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Pharmacoepidemiology and Drug Safety|October 25, 2020
Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS)Nicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Particle and Fibre Toxicology|September 22, 2007
Physicochemical characteristics and bronchial epithelial cell cytotoxicity of Folpan 80 WG(R) and Myco 500(R), two commercial forms of folpetMireille Canal-Raffin, Beatrice L'azou, Beatrice Martinez, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 8, 2018
Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) studyPierre-Michel Llorca, Julio Bobes, W Wolfgang Fleischhacker, et al.
Cardiovascular Diabetology|November 26, 2021
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims databasePatrick Blin, Patrice Darmon, Patrick Henry, et al.
Pageof 36